(Q38203471)

30 August 2017

title

HMGB1 in hormone-related cancer: a potential therapeutic target (English)

1 reference

30 August 2017

author name string

Madhuwanti Srinivasan

1

1 reference

30 August 2017

Souresh Banerjee

2

1 reference

30 August 2017

Allison Palmer

3

1 reference

30 August 2017

Guoxing Zheng

4

1 reference

30 August 2017

Aoshuang Chen

5

1 reference

30 August 2017

Maarten C Bosland

6

1 reference

30 August 2017

André Kajdacsy-Balla

7

1 reference

30 August 2017

Ramaswamy Kalyanasundaram

8

1 reference

30 August 2017

Gnanasekar Munirathinam

9

1 reference

30 August 2017

publication date

10 April 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

5

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

127-139

1 reference

Thermodynamics of HMGB1 interaction with duplex DNA.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Retroposed copies of the HMG genes: a window to genome dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

GR and HMGB1 interact only within chromatin and influence each other's residence time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1 interacts differentially with members of the Rel family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

C-Myc-independent restoration of multiple phenotypes by two C-Myc target genes with overlapping functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

High-mobility group box 1 (HMGB1) protein: friend and foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1: guiding immunity from within

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

S100 to receptor for advanced glycation end-products binding assay: looking for inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

High mobility group box 1 protein interacts with multiple Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1: endogenous danger signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Extracellular role of HMGB1 in inflammation and sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1 in development and diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

High-mobility group box 1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Toll-like receptor 4 activation in cancer progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1 and RAGE in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Direct molecular interactions between HMGB1 and TP53 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1: A Promising Therapeutic Target for Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1 promotes drug resistance in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

The redox protein HMGB1 regulates cell death and survival in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Fetal and newborn calf thymus as a source of chromatin proteins: purification of HMG-1 and HMG-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Phosphorylation of high mobility group 1 protein by phospholipid-sensitive Ca2+-dependent protein kinase from pig testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Characterization of cDNA sequences corresponding to three distinct HMG-1 mRNA species in line CHO Chinese hamster cells and cell cycle expression of the HMG-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1 Contributes to Kidney Ischemia Reperfusion Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

The high mobility group box chromosomal protein 1 is expressed in the human and rat testis where it may function as an antibacterial factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Interacting neuroendocrine and innate and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Estradiol 17-beta and progesterone modulate inducible nitric oxide synthase and high mobility group box 1 expression in human endometrium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Involvement of the TLR4 (Toll-like receptor4) signaling pathway in palmitate-induced INS-1 beta cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

The human HMGB1 promoter is modulated by a silencer and an enhancer-containing intron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Tissue damage-associated "danger signals" influence T-cell responses that promote the progression of preneoplasia to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1 release and redox regulates autophagy and apoptosis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Comprehensive molecular characterization of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Blocking the interleukin 2 (IL2)-induced systemic autophagic syndrome promotes profound antitumor effects and limits toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Cross-talk between NO and HMGB1 in lymphocytic thyroiditis and papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Dietary linoleic acid and glucose enhances azoxymethane-induced colon cancer and metastases via the expression of high-mobility group box 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Ethyl pyruvate administration inhibits hepatic tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-014-0175-0

Liposomal Ag engrafted with peptides of sequence derived from HMGB1 induce potent Ag-specific and anti-tumour immunity

21 January 2018

1 reference

12 December 2020

Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer

1 reference

12 December 2020

18α-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes.

1 reference

12 December 2020

A direct inhibitor of HMGB1 cytokine

1 reference

12 December 2020

Human pancreatic islet preparations release HMGB1: (ir)relevance for graft engraftment

1 reference

12 December 2020

Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer

1 reference

12 December 2020

A comparison of the amino-terminal sequences of two calf-thymus chromatin non-histone proteins.

1 reference

12 December 2020

RAGE ligands induce apoptotic cell death of pancreatic β-cells via oxidative stress

1 reference

12 December 2020

HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma

1 reference

12 December 2020

HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation

1 reference

12 December 2020

Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells

1 reference

12 December 2020

High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues

1 reference

12 December 2020

Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis.

1 reference

12 December 2020

[Differential proteomic analysis and function study of human prostate carcinoma cells with different osseous metastatic tendency]

1 reference

12 December 2020

Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation

1 reference

12 December 2020

Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation

1 reference

12 December 2020

Quantitative changes of high mobility group non-histone chromosomal proteins HMG1 and HMG2 during rooster spermatogenesis

1 reference

12 December 2020

[Expression and clinical significance of HMGB1 and RAGE in cervical squamous cell carcinoma].

1 reference

12 December 2020

Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer

1 reference

12 December 2020

Life after death: targeting high mobility group box 1 in emergent cancer therapies

1 reference

12 December 2020

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

1 reference

12 December 2020

HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells

1 reference

12 December 2020

HMGB1: The Central Cytokine for All Lymphoid Cells

1 reference

12 December 2020

Dealing with death: HMGB1 as a novel target for cancer therapy

1 reference

12 December 2020

Green tea extract supplement inhibition of HMGB1 release in rats exposed to cigarette smoke.

1 reference

12 December 2020

KLF4 promotes the expression, translocation, and releas eof HMGB1 in RAW264.7 macrophages in response to LPS.

1 reference

12 December 2020

Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo

1 reference

12 December 2020

Immunotherapy of metastatic renal cell cancer

1 reference

12 December 2020

Gene expression patterns associated with the metastatic phenotype in rodent and human tumors

1 reference

12 December 2020

10.1007/S12672-014-0175-0

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1048912656

0 references

1 reference